Nuvectis Pharma, Inc. SEC filings NVCT

Nuvectis Pharma, Inc. has 275 filings in SEC EDGAR's recent list, going back to Jul 30, 2021. Its latest annual report, Form 10-K, was filed on Feb 11, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
10-Q Quarterly report Aug 4, 2026 Jun 30, 2026
10-Q Quarterly report May 5, 2026 Mar 31, 2026
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
10-Q Quarterly report Aug 5, 2025 Jun 30, 2025
10-Q Quarterly report May 6, 2025 Mar 31, 2025
10-Q Quarterly report Nov 5, 2024 Sep 30, 2024
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
10-Q Quarterly report May 7, 2024 Mar 31, 2024
10-Q Quarterly report Nov 8, 2023 Sep 30, 2023
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023
10-Q Quarterly report May 10, 2023 Mar 31, 2023
10-Q Quarterly report Nov 8, 2022 Sep 30, 2022
10-Q Quarterly report Aug 10, 2022 Jun 30, 2022
10-Q Quarterly report May 12, 2022 Mar 31, 2022

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
NVCT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Fort Lee, NJ
SEC filer status
, Emerging growth company
SEC CIK
1875558

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.